BLT 0.00% 2.6¢ benitec biopharma limited

Ann: FOURTH SITE IN HEPATITIS C CLINICAL TRIAL, page-4

  1. 587 Posts.
    Why open a fourth? Maybe because as the trial progresses they will need to recruit for a phase 2/3 trial as well. I don''t know since you guys take the pessimistic route I will go for the optimistic route

    Plus they said they wouldn't report patient to patient anymore, and if they start doing it again it will make them look even more incompetent.
    Last edited by SmokeyNYY: 16/09/15
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.